Comparative antimycobacterial activities of rifampin, rifapentine, and KRM-1648 against a collection of rifampin-resistant Mycobacterium tuberculosis isolates with known rpoB mutations
about
Few amino acid positions in rpoB are associated with most of the rifampin resistance in Mycobacterium tuberculosisX-ray Crystal Structures of the Escherichia coli RNA Polymerase in Complex with BenzoxazinorifamycinsEvaluation of rifapentine in long-term treatment regimens for tuberculosis in miceEvaluation of rifalazil in a combination treatment regimen as an alternative to isoniazid-rifampin therapy in a mouse tuberculosis model.The molecular basis of resistance to isoniazid, rifampin, and pyrazinamide in Mycobacterium tuberculosisContribution of rpoB mutations to development of rifamycin cross-resistance in Mycobacterium tuberculosisTuberculosis drug resistance mutation databaseA dual read-out assay to evaluate the potency of compounds active against Mycobacterium tuberculosisGenetic evaluation of relationship between mutations in rpoB and resistance of Mycobacterium tuberculosis to rifampin.Molecular detection of rifampin and isoniazid resistance to guide chronic TB patient management in Burkina FasoGenetics and pulmonary medicine. 5. Genetics of drug resistant tuberculosisrpoB genotypes of Mycobacterium tuberculosis Beijing family isolates from East Asian countries.In vitro activity of novel rifamycins against rifamycin-resistant Staphylococcus aureusRapid detection of rifampin resistance in Mycobacterium tuberculosis isolates by heteroduplex analysis and determination of rifamycin cross-resistance in rifampin-resistant isolates.Use of DNA extracts from Ziehl-Neelsen-stained slides for molecular detection of rifampin resistance and spoligotyping of Mycobacterium tuberculosisMutations associated with pyrazinamide resistance in pncA of Mycobacterium tuberculosis complex organismsEthambutol resistance in Mycobacterium tuberculosis: critical role of embB mutationsInternational spread of MDR TB from Tugela Ferry, South Africa.Multidrug and extensively drug-resistant tuberculosis management: Evidences and controversiesAntimicrobial susceptibility testing, drug resistance mechanisms, and therapy of infections with nontuberculous mycobacteria.Can the duration of tuberculosis treatment be shortened with higher dosages of rifampicin?Predicting differential rifamycin resistance in clinical Mycobacterium tuberculosis isolates by specific rpoB mutations.Performance of a pyrosequencing platform in diagnosing drug-resistant extra-pulmonary tuberculosis in IndiaRifampin drug resistance tests for tuberculosis: challenging the gold standard.rpoB Gene mutations in rifampin-resistant Mycobacterium tuberculosis identified by polymerase chain reaction single-stranded conformational polymorphism.New drugs against tuberculosis: problems, progress, and evaluation of agents in clinical development.Mycobacterium tuberculosis strains with highly discordant rifampin susceptibility test results.New diagnostic methods for tuberculosis.Tuberculosis-spoligo-rifampin-isoniazid typing: an all-in-one assay technique for surveillance and control of multidrug-resistant tuberculosis on Luminex devicesRifampin-resistant RNA polymerase mutants of Chlamydia trachomatis remain susceptible to the ansamycin rifalazilThe future for early-stage tuberculosis drug discoveryEfficacy of novel rifamycin derivatives against rifamycin-sensitive and -resistant Staphylococcus aureus isolates in murine models of infectionDiscrimination of multidrug-resistant Mycobacterium tuberculosis IS6110 fingerprint subclusters by rpoB gene mutation analysisrpoB mutations in multidrug-resistant strains of Mycobacterium tuberculosis isolated in Italy.Multiplex PCR amplimer conformation analysis for rapid detection of gyrA mutations in fluoroquinolone-resistant Mycobacterium tuberculosis clinical isolates.Rapid determination of rifampin resistance in clinical isolates of Mycobacterium tuberculosis by real-time PCR.Evaluation of the Genotype MTBDR assay for rapid detection of rifampin and isoniazid resistance in Mycobacterium tuberculosis isolates.Rifabutin Resistance Associated with Double Mutations in rpoB Gene in Mycobacterium tuberculosis Isolates.Detection of rpoB mutations associated with rifampin resistance in Mycobacterium tuberculosis using denaturing gradient gel electrophoresis.Detection of first-line anti-tuberculosis drug resistance mutations by allele-specific primer extension on a microsphere-based platform.
P2860
Q24804809-94745837-2F53-4954-8C79-9F11D98DBDD6Q27678165-83B00730-59BC-497E-859A-E8CEE975E101Q28343604-7FCF2AC7-7541-4D1C-A91C-DBEDEE9192F1Q28344872-AB35A825-EC56-414A-918C-A70347F04288Q28362898-D8C306D7-B618-4E90-A3F6-C1FCD8883204Q28379624-CDAFF8BA-31C9-4D17-ACBE-3FCE3DC1DE16Q28474770-887EE2A5-D91D-4067-BC3E-0B838BCB385CQ28485999-DDF5CFBC-28B7-40E3-B6B0-954A8525B15DQ30857084-39F42A20-A80C-4123-8D98-B91A961F631BQ33498127-8FDA7395-A20E-4F06-9E4C-C9BBD6461742Q33630442-0678F1CA-5779-4D36-83DB-54C0E096393EQ33952004-D456375C-D759-4A32-9FC6-AB5900BB65F8Q34509698-F5F746A7-FEEF-465B-8C3F-48CAE17BD1CAQ34751498-3339CD70-4AA0-4011-851B-396A2491BDAEQ34774128-F8FECC05-FCD0-4159-B49C-6163AC918360Q35133972-04CF35C0-9BB2-46A0-875A-43CD1995AA0AQ35137537-E062ABFA-F41D-42FF-BA79-51E297320851Q35847213-8B9D465B-9647-4328-ABA8-A7F0A6D802E6Q35966734-D14ADA58-3A9D-46FE-B5EE-35D1733C119CQ36156072-083BB640-4FE8-4B3F-8776-34CC09DCC53EQ36157986-B847663D-4C31-444C-872A-8E5FB1DABDBAQ36169719-64B1455C-77F8-4B11-8156-F07F0F4136F2Q36495442-95700818-DE2C-4AC6-A957-E35EF4C1D111Q37036190-836CD7D4-D2A1-44E6-A941-E99FC636F5CEQ37075222-9505635E-86D9-4AD2-AAA4-BDA67E4B4F05Q37346929-678C1109-12D3-4BF5-8B09-34BB5F2A8113Q37410535-F3FF5B8A-4D5B-4432-AEE2-34D3FE646870Q37414160-E43FF1CE-2D35-4724-9DF3-FA4687475DC6Q37470290-518E7357-5829-4C29-B781-E2743D1AC58BQ37865419-43A61466-9787-43A6-B129-9026BAFF455CQ38358621-91443BD8-FB41-49C3-B394-CC4E3891F4AEQ39078400-4AA77B9D-5FCD-4F0E-A55B-EF56761A4228Q39451807-1961E026-BAE8-4A3A-913D-3F66DB5BEBB2Q39467894-0692E7F4-696E-4844-9857-3D729D388A03Q40469459-DC8C0A35-B4EF-4601-8C0F-A4A2D75CBBD1Q40709027-875E5B86-433B-4CB8-A7A3-4B7FEAD01A67Q41482664-B51E9048-1375-41E9-82A5-EF1137AFD5A1Q41673131-B04119C6-2D14-40D2-A369-16E11FFE602AQ42015260-BE5DE824-4AB7-471C-BE05-AD32970E318EQ42092763-33233F98-F739-4437-9B6E-CF6197D5A78B
P2860
Comparative antimycobacterial activities of rifampin, rifapentine, and KRM-1648 against a collection of rifampin-resistant Mycobacterium tuberculosis isolates with known rpoB mutations
description
1996 nî lūn-bûn
@nan
1996 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
1996 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
1996年の論文
@ja
1996年論文
@yue
1996年論文
@zh-hant
1996年論文
@zh-hk
1996年論文
@zh-mo
1996年論文
@zh-tw
1996年论文
@wuu
name
Comparative antimycobacterial ...... ates with known rpoB mutations
@ast
Comparative antimycobacterial ...... ates with known rpoB mutations
@en
Comparative antimycobacterial ...... ates with known rpoB mutations
@nl
type
label
Comparative antimycobacterial ...... ates with known rpoB mutations
@ast
Comparative antimycobacterial ...... ates with known rpoB mutations
@en
Comparative antimycobacterial ...... ates with known rpoB mutations
@nl
prefLabel
Comparative antimycobacterial ...... ates with known rpoB mutations
@ast
Comparative antimycobacterial ...... ates with known rpoB mutations
@en
Comparative antimycobacterial ...... ates with known rpoB mutations
@nl
P2093
P2860
P356
P1476
Comparative antimycobacterial ...... ates with known rpoB mutations
@en
P2093
P2860
P304
P356
10.1128/AAC.40.11.2655
P407
P577
1996-11-01T00:00:00Z